Transcranial Pulse Stimulation. a Potential Treatment for Early Dementia
NCT06730438
Summary
Alzheimer's Disease (AD) is characterized by the absence of treatments to slow, stop, or reverse its course, with patients finally losing cognitive functions, skills and independence. It is a chronic degenerative disease with high social and medical burden worldwide: AD ranked third among neurological disorders in terms of disability-adjusted life years (DALY) rates. The primary aim of the research protocol is to improve care for patients with AD, by implementing, with an innovative method, the currently available repertoire of neuromodulation techniques. For this aim, we will investigate whether Transcranial Pulse Stimulation (TPS) may induce cognitive improvement in patients with an early stage of dementia.
Eligibility
Inclusion Criteria: * age\>18 years * diagnosis of early dementia according to current international guidelines * disease duration of at least 12 months * consent to participate in the study. Exclusion Criteria: * medical instability interfering with standard neurological assessment * any contraindication to preliminary MRI for MR-based real-time neuronavigation * comorbidities which may interfere with cognitive status * any contraindication to Transcranial Pulse Stimulation.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06730438